ロード中...
Treatment of Newly Diagnosed Myeloma: Bortezomib-based Triplet
In this paper we review the options for the treatment of newly diagnosed myeloma in a patient who is a candidate for autologous stem cell transplantation. Bortezomib, lenalidomide, dexamethasone (VRD) has been studied in two randomized trials as first line therapy. In one of these trials, VRD demons...
保存先:
| 出版年: | Semin Oncol |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5266536/ https://ncbi.nlm.nih.gov/pubmed/28061990 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.seminoncol.2016.11.003 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|